Global Diabetes Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 133
Published Date: 18 Mar 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
According to our (Global Info Research) latest study, the global Diabetes Drugs market size was valued at US$ 100230 million in 2023 and is forecast to a readjusted size of USD 210010 million by 2030 with a CAGR of 11.0% during review period.
Global Diabetes Drugs key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%.
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.
This report is a detailed and comprehensive analysis for global Diabetes Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Diabetes Drugs market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Diabetes Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Diabetes Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Diabetes Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diabetes Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diabetes Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Diabetes Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Injection
Market segment by Application
Hospital
Retail Pharmacy
Major players covered
Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Conker Pharmaceuticals
Jiangsu Wanbang
Geropharm
Wockhardt
Merck Serono
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diabetes Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Diabetes Drugs, with price, sales quantity, revenue, and global market share of Diabetes Drugs from 2019 to 2024.
Chapter 3, the Diabetes Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diabetes Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Diabetes Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Diabetes Drugs.
Chapter 14 and 15, to describe Diabetes Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Diabetes Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Diabetes Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.5 Global Diabetes Drugs Market Size & Forecast
1.5.1 Global Diabetes Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Diabetes Drugs Sales Quantity (2019-2030)
1.5.3 Global Diabetes Drugs Average Price (2019-2030)
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Diabetes Drugs Product and Services
2.1.4 Novo Nordisk Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Diabetes Drugs Product and Services
2.2.4 Sanofi Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Diabetes Drugs Product and Services
2.3.4 Eli Lilly Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Eli Lilly Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Diabetes Drugs Product and Services
2.4.4 Merck Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Diabetes Drugs Product and Services
2.5.4 AstraZeneca Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 bayer
2.6.1 bayer Details
2.6.2 bayer Major Business
2.6.3 bayer Diabetes Drugs Product and Services
2.6.4 bayer Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 bayer Recent Developments/Updates
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Diabetes Drugs Product and Services
2.7.4 Boehringer Ingelheim Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Boehringer Ingelheim Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Diabetes Drugs Product and Services
2.8.4 Johnson & Johnson Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Diabetes Drugs Product and Services
2.9.4 Takeda Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Takeda Recent Developments/Updates
2.10 Tonghua Dongbao
2.10.1 Tonghua Dongbao Details
2.10.2 Tonghua Dongbao Major Business
2.10.3 Tonghua Dongbao Diabetes Drugs Product and Services
2.10.4 Tonghua Dongbao Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tonghua Dongbao Recent Developments/Updates
2.11 United Pharmaceuticals
2.11.1 United Pharmaceuticals Details
2.11.2 United Pharmaceuticals Major Business
2.11.3 United Pharmaceuticals Diabetes Drugs Product and Services
2.11.4 United Pharmaceuticals Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 United Pharmaceuticals Recent Developments/Updates
2.12 Ganli Pharmaceutical
2.12.1 Ganli Pharmaceutical Details
2.12.2 Ganli Pharmaceutical Major Business
2.12.3 Ganli Pharmaceutical Diabetes Drugs Product and Services
2.12.4 Ganli Pharmaceutical Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Ganli Pharmaceutical Recent Developments/Updates
2.13 Biocon
2.13.1 Biocon Details
2.13.2 Biocon Major Business
2.13.3 Biocon Diabetes Drugs Product and Services
2.13.4 Biocon Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Biocon Recent Developments/Updates
2.14 Conker Pharmaceuticals
2.14.1 Conker Pharmaceuticals Details
2.14.2 Conker Pharmaceuticals Major Business
2.14.3 Conker Pharmaceuticals Diabetes Drugs Product and Services
2.14.4 Conker Pharmaceuticals Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Conker Pharmaceuticals Recent Developments/Updates
2.15 Jiangsu Wanbang
2.15.1 Jiangsu Wanbang Details
2.15.2 Jiangsu Wanbang Major Business
2.15.3 Jiangsu Wanbang Diabetes Drugs Product and Services
2.15.4 Jiangsu Wanbang Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Jiangsu Wanbang Recent Developments/Updates
2.16 Geropharm
2.16.1 Geropharm Details
2.16.2 Geropharm Major Business
2.16.3 Geropharm Diabetes Drugs Product and Services
2.16.4 Geropharm Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Geropharm Recent Developments/Updates
2.17 Wockhardt
2.17.1 Wockhardt Details
2.17.2 Wockhardt Major Business
2.17.3 Wockhardt Diabetes Drugs Product and Services
2.17.4 Wockhardt Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Wockhardt Recent Developments/Updates
2.18 Merck Serono
2.18.1 Merck Serono Details
2.18.2 Merck Serono Major Business
2.18.3 Merck Serono Diabetes Drugs Product and Services
2.18.4 Merck Serono Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Merck Serono Recent Developments/Updates
2.19 Novartis
2.19.1 Novartis Details
2.19.2 Novartis Major Business
2.19.3 Novartis Diabetes Drugs Product and Services
2.19.4 Novartis Diabetes Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Novartis Recent Developments/Updates
3.1 Global Diabetes Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Diabetes Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Diabetes Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Diabetes Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Diabetes Drugs Manufacturer Market Share in 2023
3.4.3 Top 6 Diabetes Drugs Manufacturer Market Share in 2023
3.5 Diabetes Drugs Market: Overall Company Footprint Analysis
3.5.1 Diabetes Drugs Market: Region Footprint
3.5.2 Diabetes Drugs Market: Company Product Type Footprint
3.5.3 Diabetes Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Diabetes Drugs Market Size by Region
4.1.1 Global Diabetes Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Diabetes Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Diabetes Drugs Average Price by Region (2019-2030)
4.2 North America Diabetes Drugs Consumption Value (2019-2030)
4.3 Europe Diabetes Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Diabetes Drugs Consumption Value (2019-2030)
4.5 South America Diabetes Drugs Consumption Value (2019-2030)
4.6 Middle East & Africa Diabetes Drugs Consumption Value (2019-2030)
5.1 Global Diabetes Drugs Sales Quantity by Type (2019-2030)
5.2 Global Diabetes Drugs Consumption Value by Type (2019-2030)
5.3 Global Diabetes Drugs Average Price by Type (2019-2030)
6.1 Global Diabetes Drugs Sales Quantity by Application (2019-2030)
6.2 Global Diabetes Drugs Consumption Value by Application (2019-2030)
6.3 Global Diabetes Drugs Average Price by Application (2019-2030)
7.1 North America Diabetes Drugs Sales Quantity by Type (2019-2030)
7.2 North America Diabetes Drugs Sales Quantity by Application (2019-2030)
7.3 North America Diabetes Drugs Market Size by Country
7.3.1 North America Diabetes Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Diabetes Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Diabetes Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Diabetes Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Diabetes Drugs Market Size by Country
8.3.1 Europe Diabetes Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Diabetes Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Diabetes Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Diabetes Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Diabetes Drugs Market Size by Region
9.3.1 Asia-Pacific Diabetes Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Diabetes Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Diabetes Drugs Sales Quantity by Type (2019-2030)
10.2 South America Diabetes Drugs Sales Quantity by Application (2019-2030)
10.3 South America Diabetes Drugs Market Size by Country
10.3.1 South America Diabetes Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Diabetes Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Diabetes Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Diabetes Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Diabetes Drugs Market Size by Country
11.3.1 Middle East & Africa Diabetes Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Diabetes Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Diabetes Drugs Market Drivers
12.2 Diabetes Drugs Market Restraints
12.3 Diabetes Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Diabetes Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Diabetes Drugs
13.3 Diabetes Drugs Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Diabetes Drugs Typical Distributors
14.3 Diabetes Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Diabetes Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Diabetes Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Diabetes Drugs Product and Services
Table 6. Novo Nordisk Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Diabetes Drugs Product and Services
Table 11. Sanofi Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly Major Business
Table 15. Eli Lilly Diabetes Drugs Product and Services
Table 16. Eli Lilly Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Eli Lilly Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Diabetes Drugs Product and Services
Table 21. Merck Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Diabetes Drugs Product and Services
Table 26. AstraZeneca Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. bayer Basic Information, Manufacturing Base and Competitors
Table 29. bayer Major Business
Table 30. bayer Diabetes Drugs Product and Services
Table 31. bayer Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. bayer Recent Developments/Updates
Table 33. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 34. Boehringer Ingelheim Major Business
Table 35. Boehringer Ingelheim Diabetes Drugs Product and Services
Table 36. Boehringer Ingelheim Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Boehringer Ingelheim Recent Developments/Updates
Table 38. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson & Johnson Major Business
Table 40. Johnson & Johnson Diabetes Drugs Product and Services
Table 41. Johnson & Johnson Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Johnson & Johnson Recent Developments/Updates
Table 43. Takeda Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Major Business
Table 45. Takeda Diabetes Drugs Product and Services
Table 46. Takeda Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Takeda Recent Developments/Updates
Table 48. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 49. Tonghua Dongbao Major Business
Table 50. Tonghua Dongbao Diabetes Drugs Product and Services
Table 51. Tonghua Dongbao Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Tonghua Dongbao Recent Developments/Updates
Table 53. United Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. United Pharmaceuticals Major Business
Table 55. United Pharmaceuticals Diabetes Drugs Product and Services
Table 56. United Pharmaceuticals Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. United Pharmaceuticals Recent Developments/Updates
Table 58. Ganli Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Ganli Pharmaceutical Major Business
Table 60. Ganli Pharmaceutical Diabetes Drugs Product and Services
Table 61. Ganli Pharmaceutical Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Ganli Pharmaceutical Recent Developments/Updates
Table 63. Biocon Basic Information, Manufacturing Base and Competitors
Table 64. Biocon Major Business
Table 65. Biocon Diabetes Drugs Product and Services
Table 66. Biocon Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Biocon Recent Developments/Updates
Table 68. Conker Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Conker Pharmaceuticals Major Business
Table 70. Conker Pharmaceuticals Diabetes Drugs Product and Services
Table 71. Conker Pharmaceuticals Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Conker Pharmaceuticals Recent Developments/Updates
Table 73. Jiangsu Wanbang Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Wanbang Major Business
Table 75. Jiangsu Wanbang Diabetes Drugs Product and Services
Table 76. Jiangsu Wanbang Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Jiangsu Wanbang Recent Developments/Updates
Table 78. Geropharm Basic Information, Manufacturing Base and Competitors
Table 79. Geropharm Major Business
Table 80. Geropharm Diabetes Drugs Product and Services
Table 81. Geropharm Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Geropharm Recent Developments/Updates
Table 83. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 84. Wockhardt Major Business
Table 85. Wockhardt Diabetes Drugs Product and Services
Table 86. Wockhardt Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Wockhardt Recent Developments/Updates
Table 88. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 89. Merck Serono Major Business
Table 90. Merck Serono Diabetes Drugs Product and Services
Table 91. Merck Serono Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Merck Serono Recent Developments/Updates
Table 93. Novartis Basic Information, Manufacturing Base and Competitors
Table 94. Novartis Major Business
Table 95. Novartis Diabetes Drugs Product and Services
Table 96. Novartis Diabetes Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Novartis Recent Developments/Updates
Table 98. Global Diabetes Drugs Sales Quantity by Manufacturer (2019-2024) & (M Units)
Table 99. Global Diabetes Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 100. Global Diabetes Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 101. Market Position of Manufacturers in Diabetes Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 102. Head Office and Diabetes Drugs Production Site of Key Manufacturer
Table 103. Diabetes Drugs Market: Company Product Type Footprint
Table 104. Diabetes Drugs Market: Company Product Application Footprint
Table 105. Diabetes Drugs New Market Entrants and Barriers to Market Entry
Table 106. Diabetes Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Diabetes Drugs Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 108. Global Diabetes Drugs Sales Quantity by Region (2019-2024) & (M Units)
Table 109. Global Diabetes Drugs Sales Quantity by Region (2025-2030) & (M Units)
Table 110. Global Diabetes Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Global Diabetes Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 112. Global Diabetes Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 113. Global Diabetes Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 114. Global Diabetes Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 115. Global Diabetes Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 116. Global Diabetes Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 117. Global Diabetes Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 118. Global Diabetes Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 119. Global Diabetes Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 120. Global Diabetes Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 121. Global Diabetes Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 122. Global Diabetes Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Global Diabetes Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Global Diabetes Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 125. Global Diabetes Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 126. North America Diabetes Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 127. North America Diabetes Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 128. North America Diabetes Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 129. North America Diabetes Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 130. North America Diabetes Drugs Sales Quantity by Country (2019-2024) & (M Units)
Table 131. North America Diabetes Drugs Sales Quantity by Country (2025-2030) & (M Units)
Table 132. North America Diabetes Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 133. North America Diabetes Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 134. Europe Diabetes Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 135. Europe Diabetes Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 136. Europe Diabetes Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 137. Europe Diabetes Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 138. Europe Diabetes Drugs Sales Quantity by Country (2019-2024) & (M Units)
Table 139. Europe Diabetes Drugs Sales Quantity by Country (2025-2030) & (M Units)
Table 140. Europe Diabetes Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 141. Europe Diabetes Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Asia-Pacific Diabetes Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 143. Asia-Pacific Diabetes Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 144. Asia-Pacific Diabetes Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 145. Asia-Pacific Diabetes Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 146. Asia-Pacific Diabetes Drugs Sales Quantity by Region (2019-2024) & (M Units)
Table 147. Asia-Pacific Diabetes Drugs Sales Quantity by Region (2025-2030) & (M Units)
Table 148. Asia-Pacific Diabetes Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Asia-Pacific Diabetes Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 150. South America Diabetes Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 151. South America Diabetes Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 152. South America Diabetes Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 153. South America Diabetes Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 154. South America Diabetes Drugs Sales Quantity by Country (2019-2024) & (M Units)
Table 155. South America Diabetes Drugs Sales Quantity by Country (2025-2030) & (M Units)
Table 156. South America Diabetes Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 157. South America Diabetes Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 158. Middle East & Africa Diabetes Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 159. Middle East & Africa Diabetes Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 160. Middle East & Africa Diabetes Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 161. Middle East & Africa Diabetes Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 162. Middle East & Africa Diabetes Drugs Sales Quantity by Country (2019-2024) & (M Units)
Table 163. Middle East & Africa Diabetes Drugs Sales Quantity by Country (2025-2030) & (M Units)
Table 164. Middle East & Africa Diabetes Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 165. Middle East & Africa Diabetes Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 166. Diabetes Drugs Raw Material
Table 167. Key Manufacturers of Diabetes Drugs Raw Materials
Table 168. Diabetes Drugs Typical Distributors
Table 169. Diabetes Drugs Typical Customers
List of Figures
Figure 1. Diabetes Drugs Picture
Figure 2. Global Diabetes Drugs Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Diabetes Drugs Revenue Market Share by Type in 2023
Figure 4. Oral Examples
Figure 5. Injection Examples
Figure 6. Global Diabetes Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Diabetes Drugs Revenue Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Retail Pharmacy Examples
Figure 10. Global Diabetes Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Diabetes Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Diabetes Drugs Sales Quantity (2019-2030) & (M Units)
Figure 13. Global Diabetes Drugs Price (2019-2030) & (US$/Unit)
Figure 14. Global Diabetes Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Diabetes Drugs Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Diabetes Drugs by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 Diabetes Drugs Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 Diabetes Drugs Manufacturer (Revenue) Market Share in 2023
Figure 19. Global Diabetes Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Diabetes Drugs Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Diabetes Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Diabetes Drugs Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Diabetes Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Diabetes Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Diabetes Drugs Revenue Market Share by Application (2019-2030)
Figure 31. Global Diabetes Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Diabetes Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Diabetes Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Diabetes Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Diabetes Drugs Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Diabetes Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Diabetes Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Diabetes Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Diabetes Drugs Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. France Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Diabetes Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Diabetes Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Diabetes Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Diabetes Drugs Consumption Value Market Share by Region (2019-2030)
Figure 52. China Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. India Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Diabetes Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Diabetes Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Diabetes Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Diabetes Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Diabetes Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Diabetes Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Diabetes Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa Diabetes Drugs Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa Diabetes Drugs Consumption Value (2019-2030) & (USD Million)
Figure 72. Diabetes Drugs Market Drivers
Figure 73. Diabetes Drugs Market Restraints
Figure 74. Diabetes Drugs Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Diabetes Drugs in 2023
Figure 77. Manufacturing Process Analysis of Diabetes Drugs
Figure 78. Diabetes Drugs Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novo Nordisk Sanofi Eli Lilly Merck AstraZeneca bayer Boehringer Ingelheim Johnson & Johnson Takeda Tonghua Dongbao United Pharmaceuticals Ganli Pharmaceutical Biocon Conker Pharmaceuticals Jiangsu Wanbang Geropharm Wockhardt Merck Serono Novartis
Related Reports
18 Mar 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
